This case report highlights that daunorubicin can cause early, severe cardiac toxicity presenting as pericarditis and cardiovascular collapse even at lower cumulative doses (210 mg/m2).
No takes yet. Share an insight, caveat, or question.
Early daunorubicin cardiotoxicity may occur at low doses; case report leaves open need for prospective monitoring studies.
David T. Harrison (1976) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: